Urothelial cancer: Once there were urologists, now oncologists joined, what about nephrologists?
نویسندگان
چکیده
منابع مشابه
Once there were twenty.
Aminoacyl-tRNA synthetases play a central role in protein synthesis by covalently linking the correct amino acid to the correct tRNA (1). Each aminoacyl-tRNA is then carried to the ribosome where it interacts with the cognate trinucleotide codon on the mRNA and transfers the amino acid onto a growing polypeptide chain. Work on tRNAs and aminoacyltRNA synthetases from bacteria, fungi, plants, an...
متن کاملA role for pediatric oncologists/urologists?!
Like testicular cancer in adulthood, the Wilms' tumor or nephroblastoma in childhood is an example of a curable malignant disease. The review by Huszno et al. in this Journal gives an overview concerning diagnosis and treatment of adult Wilms' tumors [1]. This tumor entity was first described in 1814 by Rance and in 1899 Max Wilms, a German surgeon, described this tumor in detail [2]. Beckwith ...
متن کاملWhat adult nephrologists should know about childhood blood pressure.
HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 1989; 35: 1358–1370 33. Mazbar SA, Schoenfeld PY, Humphreys MH. Renal involvement in patients infected with HIV: experience at San Francisco General hospital. Kidney Int 1990; 37: 1325–1332 34. Shahinian V, Rajaraman S, Borucki M et al. Prevalence of HIVassociated nephropathy in autopsies of HIV-infected patien...
متن کاملWhat do oncologists need to know about biosimilar products?
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of "comparability" or "no clinically meaningful differences" as compared to its reference biologic ...
متن کاملWhat should oncologists know about cytogenetics in solid tumors?
Despite the fact that gross chromosome changes in malignant tumors were first described in human solid tumors more than 100 years ago by Arnold [1], cytogenetic analysis of solid tumors is still in its infancy compared to studies of leukemic cells [for review see 2, 3]. Advances in solid tumor cytogenetics have been and still are at the mercy of methodology, with the most limiting factors being...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Onco-Nephrology
سال: 2018
ISSN: 2399-3693,2399-3707
DOI: 10.1177/2399369318805367